ub8体育平台

<input id="uoa60"><acronym id="uoa60"></acronym></input>
<input id="uoa60"></input>
  • <menu id="uoa60"></menu>
  • <input id="uoa60"></input>
    <menu id="uoa60"></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <object id="uoa60"><acronym id="uoa60"></acronym></object>
  • <input id="uoa60"></input>
    <menu id="uoa60"><u id="uoa60"></u></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <menu id="uoa60"><u id="uoa60"></u></menu>
  • <input id="uoa60"><u id="uoa60"></u></input>
  • 财新传媒
    财新英文 > 要闻 > 正文

    It’s Too Early to Get Excited About Gilead’s New Coronavirus Drug, Experts Say

    2020年02月07日 20:33 来源于 财新网
    Although remdesivir so far appears to be more effective at fighting the deadly virus than other antivirals, the evidence remains light
    Experts say Gilead’s drug remdesivir looks promising, but that it’s far too early to get excited. Photo: IC Photo

    Shares in American biotech company Gilead Sciences Inc. climbed to a more than six-month high this week on news that it had been given the green light to start human trials of an experimental antiviral drug on coronavirus patients in China.

    版面编辑:喻竹杨洋
    财新私房课
    好课推荐
    
    <input id="uoa60"><acronym id="uoa60"></acronym></input>
    <input id="uoa60"></input>
  • <menu id="uoa60"></menu>
  • <input id="uoa60"></input>
    <menu id="uoa60"></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <object id="uoa60"><acronym id="uoa60"></acronym></object>
  • <input id="uoa60"></input>
    <menu id="uoa60"><u id="uoa60"></u></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <menu id="uoa60"><u id="uoa60"></u></menu>
  • <input id="uoa60"><u id="uoa60"></u></input>
  • 大发彩票官网手机版

    吉利彩的网页版

    manbet

    千亿国际 qy8千亿国际

    大发游戏

    同乐城 同乐城官网

    龙八|国际下载

    九州体育亚洲9入口

    pt电子游戏平台